Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malaria transmission-blocking vaccines.

D C Kaslow1, I C Bathurst, P J Barr

  • 1Molecular Vaccine Section, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.

Trends in Biotechnology
|November 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency.

Vaccine·2016
Same author

The epidemiology of red cell transfusion.

Vox sanguinis·2010
Same author

Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion.

Cell death and differentiation·2003
Same author

Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.

Vaccine·2001
Same author

Short report: IgG1/IgG3 antibody responses to various analogs of recombinant ypfmsp119--a study in immune adults living in areas of Plasmodium falciparum transmission.

The American journal of tropical medicine and hygiene·2001
Same author

Serologic responses of Korean soldiers serving in malaria-endemic areas during a recent outbreak of Plasmodium vivax.

The American journal of tropical medicine and hygiene·2001
Same journal

Engineering environmental bacteria for whole-cell PET hydrolysis and assimilation.

Trends in biotechnology·2026
Same journal

Acoustic cavitation-enhanced lymphatic trafficking of inhaled bacterial-sourced biohybrid vaccines for antitumor immunity.

Trends in biotechnology·2026
Same journal

Make uphill thermodynamics downhill in pathway design.

Trends in biotechnology·2026
Same journal

Engineering a capture-bioremediate-release microbial biofilm for simultaneous bioremediation of microplastics and adsorbed heavy metals.

Trends in biotechnology·2026
Same journal

Engineered bacterial biofilms for biotechnological applications.

Trends in biotechnology·2026
Same journal

Multiscale and programmable engineering of edible mushroom mycelium-based materials.

Trends in biotechnology·2026
See all related articles

Antibodies targeting sexual stage Plasmodium falciparum surface proteins can block malaria parasite transmission. This research highlights transmission-blocking vaccines as a key strategy against this deadly disease.

Area of Science:

  • Immunology
  • Parasitology
  • Vaccinology

Background:

  • Malaria remains a significant global health threat, primarily transmitted by the Plasmodium falciparum parasite.
  • Controlling malaria spread necessitates innovative strategies beyond current interventions.

Purpose of the Study:

  • To investigate the efficacy of antibodies against Plasmodium falciparum sexual stage surface proteins in blocking parasite transmission.
  • To underscore the potential of transmission-blocking vaccines in malaria control.

Main Methods:

  • Utilizing immunological assays to identify and characterize antibodies targeting Plasmodium falciparum sexual stages.
  • Evaluating the transmission-blocking capabilities of these antibodies in experimental models.

Main Results:

Related Experiment Videos

  • Antibodies targeting specific surface proteins of Plasmodium falciparum sexual stages demonstrated complete blockade of parasite transmission.
  • This confirms the critical role of these targets in the parasite's lifecycle and infectivity.

Conclusions:

  • Antibodies to sexual stage surface proteins are highly effective in preventing malaria transmission.
  • Transmission-blocking vaccines offer a promising and novel approach for the global control of malaria.